Up-regulation of MDR1 function and expression by cisplatin in LLC-PK1 cells

Kohji Takara1, Masayuki Tsujimoto, Misato Kokufu

  • 1Department of Hospital Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto, Japan. takara@mb.kyoto-phu.ac.jp

Insights

Cisplatin treatment increases multidrug resistance 1 (MDR1) expression and function in kidney cells. This suggests transient cisplatin exposure can up-regulate MDR1, potentially affecting drug efficacy.

Area of Science:

  • Nephrology
  • Pharmacology
  • Molecular Biology

Background:

  • The multidrug transporter MDR1/P-glycoprotein plays a crucial role in drug efflux from cells.
  • Understanding how chemotherapy agents like cisplatin interact with MDR1 in renal cells is vital for optimizing treatment outcomes.

Purpose of the Study:

  • To investigate the impact of cisplatin on the function and expression of MDR1 in kidney epithelial cells.
  • To determine if cisplatin exposure alters cellular sensitivity to MDR1 substrates.

Main Methods:

  • Utilized porcine kidney LLC-PK1 cells, which mimic renal proximal tubular cells.
  • Assessed cell sensitivity to paclitaxel, Rhodamine123 uptake/efflux, and MDR1 mRNA levels after cisplatin pretreatment.
  • Evaluated the effect of ciclosporin on Rhodamine123 efflux.

Main Results:

  • Cisplatin pretreatment shifted the paclitaxel growth inhibitory curve to higher concentrations.
  • Rhodamine123 uptake decreased, while efflux significantly increased post-cisplatin exposure.
  • Ciclosporin treatment reversed the enhanced Rhodamine123 efflux, confirming MDR1 involvement.
  • MDR1 mRNA expression levels were elevated by cisplatin exposure.

Conclusions:

  • Transient exposure to cisplatin leads to the up-regulation of MDR1 in LLC-PK1 cells.
  • Cisplatin's effect on MDR1 may influence the transport of other drugs within the kidneys.
  • Further research is warranted to explore the clinical implications of cisplatin-induced MDR1 modulation in renal drug transport.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...